CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 203 enrolled
Drug / intervention
Probiotic +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00113659
NCT00113659N/ACompleted
CompareCT.gov

Trial of Infant Probiotic Supplementation to Prevent Asthma

Montefiore Medical Center·interventional·Posted Jun 10, 2005·Updated Jun 11, 2024

In Brief

A clinical study evaluating Probiotic and Placebo for Asthma. Completed, enrolled 203 participants across 1 site.

Detailed Summary

The goal of the study is to understand the mechanisms of how antigen presentation affects the developing immune system and subsequently affects susceptibility to, or protects against, asthma development. This randomized controlled study will test the effectiveness of daily supplementation of Lactobacillus GG for the first 6 months of life on the early immunological development of asthma.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAsthma
CountriesUnited States
CollaboratorsNational Heart, Lung, and Blood Institute (NHLBI)

Timeline

N/ACompletedFinished
20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJun 10, 2005
Enrollment StartJun 1, 2005
Primary CompletionMay 1, 2014
TodayJul 2, 2026
Enrollment to primary: 8.9 yearsPosted 21.1 years ago

Interventions

Probioticdietary

Daily dose of ten to the tenth colony-forming units of Lactobacillus GG and 225 mg of inulin for the first 6 months of life.

Placebodietary

Daily dose of placebo supplement containing 325mg inulin for the first 6 month of life.